Table 3.

Comparison of symptoms and complications of treatment between case and control groups

Symptom	Admission			1 week			2 weeks			3 weeks			4 weeks
	Ctl	Cs	P value	Ctl	Cs	P value	Ctl	Cs	P value	Ctl	Cs	P value	Ctl	Cs	P value
Rectal bleeding	21	26	0.388	19	19	0.772	18	15	0.140	15	13	0.884	12	8	0.622
Incomplete defecation	31	26	0.505	27	24	0.915	25	15	0.007*	21	11	0.075	21	12	0.062
Anal pain	30	21	0.073	28	21	0.391	21	11	0.036*	16	10	0.255	15	6	0.025*
Anal irritation	22	23	0.946	20	18	0.816	13	10	0.411	9	6	0.635	6	5	0.732
Anal discharge	13	13	0.750	11	6	0.501	8	5	0.871	7	4	0.782	4	2	0.418
Anal discomfort	25	22	0.490	24	17	0.058	19	12	0.313	15	8	0.121	13	7	0.395
Complication
Diarrhoea	10	12	0.511	6	4	0.471	4	3	0.512	2	1	0.612	2	0	0.259
Nausea	9	10	0.990	2	3	0.990	0	1	0.512	0	1	0.512	0	0	1
Vomiting	5	4	0.540	0	2	0.209	0	1	0.512	0	1	0.512	0	0	1
Skin rash	12	9	0.230	5	3	0.189	2	2	1	2	0	0.230	1	0	0.512
Pruritus	13	14	0.784	7	5	0.960	2	4	0.616	1	1	1	1	0	0.512
Headache	19	21	0.847	4	11	0.087	1	3	0.242	0	3	0.480	0	0	1
Vertigo	15	18	0.943	4	7	0.492	1	2	0.612	0	1	0.512	0	0	1

Number of individuals in case (Cs) and control (Ctl) groups are 44 and 42, respectively (n_total=86).

*Significant differences between case and control groups.